Madrigal Pharmaceuticals (MDGL) Superinvestor holders
17 of the superinvestors we track hold Madrigal Pharmaceuticals (MDGL) in their latest 13F filings, $1.2B in total.
Summary
The largest holder is John Paulson (Paulson & Co), with $720M, 27.9% of the portfolio.
In their latest quarter: 3 opened a new position, 5 added, 7 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| John Paulson Paulson & Co |
Trimmed | 1,340,020 | $720M | 27.9% | Q2 2026 |
| Artisan Partners | Added | 210,205 | $113M | 0.2% | Q2 2026 |
| Brandon Haley Holocene Advisors |
New position | 152,924 | $82M | 0.2% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 137,029 | $74M | 0.1% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Added | 109,325 | $59M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 101,859 | $55M | 0.0% | Q2 2026 |
| Takis Sparaggis Alkeon Capital Management |
Held | 80,000 | $43M | 0.2% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 45,942 | $25M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 35,071 | $19M | 0.0% | Q2 2026 |
| WCM Investment Management | Trimmed | 22,985 | $12M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 15,827 | $8M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 11,509 | $6M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 6,447 | $3M | 0.1% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | 4,500 | $2M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 2,670 | $1M | 0.0% | Q3 2026 |
| Ensign Peak Ensign Peak Advisors |
Held | 881 | $473,053 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 566 | $303,914 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 17 |
| Q1 2026 | 18 |
| Q4 2025 | 19 |
| Q3 2025 | 17 |
| Q2 2025 | 13 |
| Q1 2025 | 11 |
| Q4 2024 | 12 |
| Q3 2024 | 9 |
Questions about Madrigal Pharmaceuticals
Which superinvestors own Madrigal Pharmaceuticals?
17 of the superinvestors we track hold Madrigal Pharmaceuticals (MDGL) in their latest 13F filings, $1.2B in total. John Paulson, Artisan Partners, Brandon Haley, Steve Cohen, Hersh Cohen, Paul Marshall.
Who is the largest superinvestor holder of MDGL?
The largest holder is John Paulson (Paulson & Co), with $720M, 27.9% of the portfolio.
From Madrigal Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.